Book a demo

Chemical intelligence powered by cypris.ai

(25R)-5alpha-Spirostan-3beta-ol

5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-ol · also: 3-Episarsasapogenin, (25S)-Spirostan-3beta-ol, (25r)-5a-spirostan-3b-ol, Spirostan-3-ol,5.beta.,25S)-, Spirostan-3-ol,5.alpha.,25R)-, (25R)-5.alpha.-Spirostan-3.beta.-ol

FormulaC27H44O3
Mol. weight416.646
PubChem CID219836
InChIKeyGMBQZIIUCVWOCD-UHFFFAOYSA-N
SMILESCC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1
1,061Patents
30Research papers
69Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Lipotec SA39
2L'Oréal SA37
3Symrise AG32
4Pfizer Inc31
5Pfizer Corp SRL29
6Patheon Softgels Inc27
7Procter and Gamble Co23
8Fidia Farmaceutici SpA22
9DIC Corp21
10Fidia SpA21

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations565
2A61PTherapeutic activity (drug indications)368
3A61QCosmetics, personal care224
4C07J159
5C08LPolymer compositions (blends)69
6A61LSterilising / disinfecting materials59
7G01NInvestigating / analysing materials48
8A01NPreservation of bodies; biocides; pest repellents41
9C08B41
10A23LFoods and beverages (general)36

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Phytochemical Studies and Bioactivities2
2Bee Products Chemical Analysis1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Bertrand LiagreUniversité de Limoges5
2Cécile CorbièreUniversité de Limoges4
3Jean‐Louis BeneytoutUniversité de Limoges3
4Guoping CaiUniversity Town of Shenzhen2
5Hiroyuki TanakaKyushu University2
6Hua ZhouUniversity Town of Shenzhen2
7Naili WangShenyang Pharmaceutical University2
8Pascale Vergne‐SalleHôpital Dupuytren2
9Scott W. NelsonIowa State University2
10Xi YangAir Force Medical University2

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of (25R)-5alpha-Spirostan-3beta-ol?

(25R)-5alpha-Spirostan-3beta-ol has a molecular formula of C27H44O3 and a molecular weight of 416.646.

Which companies hold the most patents related to this compound?

The leading patent assignees are Lipotec SA with 39 patents, L'Oréal SA with 37 patents, and Symrise AG with 32 patents.

What are the primary patent classification areas for this compound?

The primary patent classifications are A61K (pharmaceutical preparations) with 565 patents, A61P (therapeutic applications) with 368 patents, and A61Q (cosmetics and personal care) with 224 patents.

Which research institutions have published studies on this compound?

Leading researchers include Bertrand Liagre from Université de Limoges with 5 papers, Cécile Corbière from Université de Limoges with 4 papers, and Jean‐Louis Beneytout from Université de Limoges with 3 papers.

How has patent activity for this compound trended in recent years?

Patent activity showed 69 patents filed in the last 3 years. Recent year data indicates 50 patents in 2016, declining to 21 in 2024, with 29 patents recorded in 2025 and only 4 in 2026.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial